» Articles » PMID: 11264538

Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue

Overview
Journal Science
Specialty Science
Date 2001 Mar 27
PMID 11264538
Citations 784
Authors
Affiliations
Soon will be listed here.
Abstract

Many intracellular pathogens infect a broad range of host tissues, but the importance of T cells for immunity in these sites is unclear because most of our understanding of antimicrobial T cell responses comes from analyses of lymphoid tissue. Here, we show that in response to viral or bacterial infection, antigen-specific CD8 T cells migrated to nonlymphoid tissues and were present as long-lived memory cells. Strikingly, CD8 memory T cells isolated from nonlymphoid tissues exhibited effector levels of lytic activity directly ex vivo, in contrast to their splenic counterparts. These results point to the existence of a population of extralymphoid effector memory T cells poised for immediate response to infection.

Citing Articles

LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment.

Xue Y, Hou X, Zhong Y, Zhang Y, Du S, Kang D Nat Commun. 2025; 16(1):2198.

PMID: 40038251 PMC: 11880362. DOI: 10.1038/s41467-025-57149-2.


Ligands for Intestinal Intraepithelial T Lymphocytes in Health and Disease.

Hada A, Xiao Z Pathogens. 2025; 14(2).

PMID: 40005486 PMC: 11858322. DOI: 10.3390/pathogens14020109.


Effects of protein boosters on antibody responses.

Awakoaiye B, Dangi T, Penaloza-MacMaster P bioRxiv. 2025; .

PMID: 39990358 PMC: 11844364. DOI: 10.1101/2025.02.08.637239.


Streptococcus lutetiensis inhibits CD8 IL17A TRM cells and leads to gastric cancer progression and poor prognosis.

Wang H, You W, Zhu Z, Zhang Y, Hu C, Lu J NPJ Precis Oncol. 2025; 9(1):43.

PMID: 39924593 PMC: 11808082. DOI: 10.1038/s41698-025-00810-2.


Differential predictive value of resident memory CD8T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.

Paolini L, Tran T, Corgnac S, Villemin J, Wislez M, Arrondeau J J Immunother Cancer. 2024; 12(12.

PMID: 39631852 PMC: 11624836. DOI: 10.1136/jitc-2024-009440.